Mon. Jul 22nd, 2024

FDA launches investigation into diabetes drug

DAYTON (KSMX)- The U.S. Food and Drug Administration is investigating to see if a potentially cancer-causing chemical has contaminated a diabetes drug.

The impacted drug is Metformin. Metformin is the most popular treatment for patients with Type 2 Diabetes. It’s also often the first prescription offered for Polycystic Ovary Syndrome patients who have insulin resistance.

Some metformin medicines in other countries have been found to contain the carcinogen N-Nitrosodimethylamine (NDMA). The FDA says the levels of NDMA in those medicines are within the range of what naturally occurs in some foods and water.

“The FDA is investigating whether metformin in the U.S. market contains NDMA, and whether it is above the acceptable daily intake limit of 96 nanograms.”

NDMA’s presence in blood pressure and heartburn medications recently prompted full recalls. The FDA is

expanding testing requirements for such medications to ensure the drugs do not have NDMA above the acceptable daily intake limit.

If you have questions about the investigation, you can call the FDA at 888-INFO-FDA.

About Post Author